Muna Therapeutics ApS
Developing small molecule therapies to treat and stop neurodegenerative diseases.
Overview
- 17
- Employees
- Unknown
- Revenue
- 2020
- Founded
Key Decision Makers
Luc Dochez
Board Member
Lars Christian Roenn
Vice-President, Head of Operations
Manuela Polydoro
Vice-President, Head of Translational Medicine
David Howe
Vice-President, Head of Early Clinical Development
+19 more contacts in Funnelfeedr
Description
Muna Therapeutics is a biotechnology company focused on discovering and developing disease-modifying small molecule therapies for neurodegenerative disorders. Their research targets conditions such as Alzheimer’s and Parkinson’s disease by enhancing brain resilience and normalizing microglial functi...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- APS
- VAT Number
- DK41142871
Decision Makers
23 contacts in FunnelfeedrLuc Dochez
Board Member
Lars Christian Roenn
Vice-President, Head of Operations
Manuela Polydoro
Vice-President, Head of Translational Medicine
David Howe
Vice-President, Head of Early Clinical Development
Jakob Busch-Petersen
Chief Development Officer
Pernille Aasholm
Vice-President, Head of People
Peter Flagstad
Vice-President, Head of Program Management
Donald Nicholson
Independent Chair
Camilla Hansen
Board Member
Laia Crespo-Martin
Board Member
Niels Plath
Chief Scientific Officer
Anders Hinsby
Chief Operating Officer
Bart De Strooper
Chief Scientific Advisor and Chair of the Scientific Advisory Board
Rita Balice-Gordon
Chief Executive Officer
Joachim Vilstrup
Head of Protein Chemistry and Structural Biology
Henrijette Richter
Board Member
Eileen McGuire
Board Member
Maria Dalby
Head of Bioinformatics
Cillian King
Board Member
Simon Glerup
Scientific Founder and Member of the Scientific Advisory Board
Jonathan van Eyll
Vice-President, Leuven Site Head and Project Head, Alzheimer’s MiND-MAP GSK Alliance
Heleen Verlinden
Alliance Manager
Elizabeth Birch
Vice-President, Head of Business Development
Similar Companies
20 similar companies in Funnelfeedr
CONTERA PHARMA A/S
20 employeesDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Evaxion A/S
47 employeesAI-driven TechBio company developing personalized vaccines for cancer and infections.
BIOGEN (DENMARK) A/S
14 employeesGlobal biotechnology company developing innovative therapies for serious neurological diseases.
Neumirna Therapeutics ApS
9 employeesDeveloping miRNA-based therapies to treat complex neurological disease root causes.
Grespo AB
0 employeesYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Muna Therapeutics ApS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo